Roche Wins EU Approval for Susvimo in Wet AMD
Basel, Switzerland, September 21, 2026 Roche has announced that the European Commission has approved Susvimo® (ranibizumab 100 mg/mL) for...
Eye Disease
Advertisement
OKYO Pharma Boosts Cash to Advance Phase 3 Urcosimod Trial
London, United Kingdom, and New York, NY | July 20, 2026 OKYO Pharma Limited announced the filing of its...
Lexitas and Ocusun Dose First Patient in Cataract Trial
DURHAM, N.C. & GUANGZHOU, China, July 14, 2026 Lexitas Pharma Services and Ocusun have announced the enrollment of the...
OKYO Pharma Receives FDA Support for Phase 3 Trial
LONDON and NEW YORK, July 8, 2026 OKYO Pharma announced positive feedback from its U.S. Food and Drug Administration...
Oculis Initiates PREDICT-1 Trial for Licaminlimab in Dry Eye Disease
Oculis, Zug, Switzerland, June 9, 2026 Oculis announced that the first patient has been randomized in the PREDICT-1 registrational...
Advertisements
Renerva Implants First PNM-CAP Device for Neuroma Pain
PITTSBURGH, May 13, 2026 Renerva, Inc. announced the successful first-in-human implantation of its investigational PNM-CAP™ device, marking a major...
Astellas Reports IZERVAY Reduced Vision Decline in GA Patients
NORTHBROOK, Ill., May 12, 2026 Astellas Pharma US announced new clinical findings showing that IZERVAY® (avacincaptad pegol intravitreal solution)...
Nona Biosciences Appoints Josh Xiao as New CSO
CAMBRIDGE, Mass., May 6, 2026 Nona Biosciences, a global biotechnology company specializing in biotherapeutic discovery and AI-driven drug development...
Bayer to Acquire Perfuse Therapeutics in $2.45B Deal
BERLIN, Germany, and SAN FRANCISCO, Calif., May 6, 2026 Bayer has announced an agreement to fully acquire Perfuse Therapeutics...
Advertisement
